adult clinical studies, page-2

Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #

First 2 Last

Share
Profile

Follow
dman0

2,745 Posts.

1320

16/06/16

10:17

Post #: 18044267
Share

Originally posted by dman0 ↑

There's been a lot of comments on the Charting thread regarding share price projections following the upcoming release of adult clinical study results. For the most part, I hate to burst you bubble guys but I doubt very much if we'll see some of the valuations many of you are hoping for (at least not just yet). I use the past as a predictor of the future. On 03/03/2016 RAP announced "breakthrough performance in paediatric clinical study" (see below). The closing share price was 0.13 prior to the announcement and 0.19 after the announcement, representing a 41% gain. Therefore IF adult clinical study results are as good as the paediatric clinical study results and assuming the closing share price before the announcement is 0.40, we may see a 41% gain and a closing share price of 0.56. I believe further inflation of the market cap/share price will come with commercialisation of the technology and/or FDA approval. It's worth noting that when ResApp announced "updated paediatric clinical study results" the share price went down 4%. Good luck to all, and lets try to keep the Charting thread for what it was intended. Cheers.

View attachment 195282

Expand

I should add that if, as I suspect, we see price consolidation between here and 0.45 towards the time of the announcement, then the target would be 0.63

RAP Price at posting: 40.5¢ Sentiment: Buy Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

LML

Lincoln Minerals to kick off fieldwork at Yallunda uranium project in the nuclear state, SA

TNC

True North shares jump on positive activity report as Cloncurry aims for Q1 production deadline

MKT

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

QGL

Quantum Graphite snags new exploration licence in SA ahead of maiden drilling

WML

Woomera kicks off 2-pronged drilling at Mongolia's Bronze Fox Cu-Au play

There are more pages in this discussion • 18 more messages in this thread...

First 2 Last

Add RAP (ASX) to my watchlist

adult clinical studies, page-2

Top Stories

Lincoln Minerals to kick off fieldwork at Yallunda uranium project in the nuclear state, SA

True North shares jump on positive activity report as Cloncurry aims for Q1 production deadline

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

Quantum Graphite snags new exploration licence in SA ahead of maiden drilling

Woomera kicks off 2-pronged drilling at Mongolia's Bronze Fox Cu-Au play

Featured News